1. bpc-157 patch patches transdermal Push Patch uses time-based transdermal delivery to provide a steady release bpc-157 transdermal patch Some peptides – Age BPC-157 Transdermal Patch – Mixing Kit (30mL Bacteriostatic Size:10mg Pre-Filled Pen (SubQ) Cellular Signaling

1. bpc-157 patch patches transdermal Push Patch uses time-based transdermal delivery to provide a steady release bpc-157 transdermal patch Some peptides – Age BPC-157 Transdermal Patch – Mixing Kit (30mL Bacteriostatic Size:10mg Pre-Filled Pen (SubQ) Cellular Signaling

Mixing Kit (30mL Bacteriostatic water + Mixing Syringe) | Defy Medical

Composition GHK-Cu: 50 mg BPC-157: 10 mg TB-500 (Thymosin Beta 4): 10 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined evaluation of copper peptide, BPC-157, and TB-500 in in-vitro or ex-vivo assay systems Assay development, including chromatographic separation of three co-formulated peptides Stability characterization of a three-analyte lyophilized blend under laboratory storage conditions Method documentation for HPLC/LC-MS identity and purity assessments Documentation Analysis Report Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability

Cellular Signaling

Size:10mg Pre-Filled Pen (SubQ)

It was actually FDA-approved twice : once in 1990 as a diagnostic agent for GH deficiency, and again in 1997 as a treatment for childhood GH deficiency